No Data
No Data
J.P. Morgan Maintains Treace Medical Concepts(TMCI.US) With Hold Rating, Raises Target Price to $10
Earnings Call Summary | Treace Medical Concepts(TMCI.US) Q4 2024 Earnings Conference
Morgan Stanley Initiates Treace Medical Concepts(TMCI.US) With Hold Rating, Announces Target Price $10
Lake Street Maintains Treace Medical Concepts(TMCI.US) With Buy Rating, Maintains Target Price $14.5
Treace Medical Concepts (TMCI) Receives a Hold From Morgan Stanley
Treace Medical Concepts (TMCI) Receives a Hold From Stifel Nicolaus